<DOC>
	<DOCNO>NCT00447278</DOCNO>
	<brief_summary>The purpose study demonstrate atomoxetine superior early standard therapy ( treatment investigator considers appropriate initiate treatment Attention-Deficit/Hyperactivity Disorder [ ADHD ] ) long term function approximately 400 child adolescent ADHD . Patients pharmacological naïve prior entry study .</brief_summary>
	<brief_title>A Study Comparing Effect Atomoxetine Versus Other Standard Care Therapy Long Term Functioning Attention-Deficit/Hyperactivity Disorder ( ADHD ) Children Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Inclusion criterion : 6 16 year old Diagnosis ADHD accord Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSM IV ) confirm Kiddie Schedule Affective Disorders Schizophrenia School Aged ChildrenPresent Lifetime Version ( SADS PL ) Pharmacological naïve Normal intelligence assess investigator Each patient ( and/or legally authorize patient representative require local law ) must understand nature study must sign Informed Consent Document . Exclusion criterion History bipolar disorder , history psychosis autism spectrum disorder History seizure disorder Significant prior current medical condition History alcohol drug abuse within past 3 month Patients take concurrently exclude medication study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>